Comorbidities and Outcomes: Advancing the Field Comes at a Price

por Sorror, Mohamed L.
Publicado 2011

How I assess comorbidities before hematopoietic cell transplantation

por Sorror, Mohamed L.
Publicado 2013

Defining Vulnerability in Allogeneic Transplants is More Complicated than the Two Numerical Digits of Age

por Sorror, Mohamed L.
Publicado en Leuk Lymphoma (2015)

Role of Comorbidities in Optimizing Decision-Making for Allogeneic Hematopoietic Cell Transplantation

por Sorror, Mohamed L., Storb, Rainer F.
Publicado 2010

Risk Assessment before Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia

por Sorror, Mohamed L., Appelbaum, Frederick R.
Publicado 2013

Validation of the Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) in Single and Multiple Institutions: Limitations and Inferences

por Sorror, Mohamed L., Storer, Barry, Storb, Rainer F.
Publicado 2009

Revised Acute Myeloid Leukemia Composite Model Using the 2017 European LeukemiaNet Risk Classification

por Sorror, Mohamed L., Storer, Barry E., Nyland, Jennifer, Estey, Elihu H.
Publicado en JAMA Oncol (2019)

Impact of Acute Kidney Injury on Long Term Mortality after Nonmyeloablative Hematopoietic Cell Transplantation

por Parikh, Chirag R., Yarlagadda, Sri G, Storer, Barry, Sorror, Mohamed, Storb, Rainer, Sandmaier, Brenda
Publicado 2008

Moderate or Severe Valvular Heart Disease and Outcomes in Allogeneic Stem Cell Transplantation

por Brusen, Robin M, Cheng, Richard K, Masri, Sophia C, Leedy, Douglas, Sorror, Mohamed L
Publicado en Int J Cardiol (2019)

A Pilot Pharmacologic Biomarker Study in HLA-Haploidentical Hematopoietic Cell Transplant Recipients

por Bemer, Meagan J., Sorror, Mohamed, Sandmaier, Brenda M., O’Donnell, Paul V., McCune, Jeannine S.
Publicado 2013

The Association between Chronic Conditions, End-of-Life Health Care Use, and Documentation of Advance Care Planning among Patients with Cancer

por McDermott, Cara L., Engelberg, Ruth A., Sibley, James, Sorror, Mohamed L., Curtis, J. Randall
Publicado en J Palliat Med (2020)

Feasibility of geriatric assessment before transplant conditioning regimen in older HCT recipients

por Littlejohn, Kai, Tomlinson, Kelly, Armenian, Saro H., Nakamura, Ryotaro, Sorror, Mohamed L., McCune, Jeannine S.
Publicado en Bone Marrow Transplant (2020)

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia

por Sorror, Mohamed L., Storer, Barry E., Maloney, David G., Sandmaier, Brenda M., Martin, Paul J., Storb, Rainer
Publicado 2008

The Impact of Donor Type and ABO Incompatibility on Transfusion Requirements after Nonmyeloablative Hematopoietic Cell Transplantation (HCT)

por Wang, Zejing, Sorror, Mohamed L., Leisenring, Wendy, Schoch, Gary, Maloney, David G., Sandmaier, Brenda M., Storb, Rainer
Publicado 2010

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

por Sorror, Mohamed L., Maris, Michael B., Storb, Rainer, Baron, Frederic, Sandmaier, Brenda M., Maloney, David G., Storer, Barry
Publicado 2005

What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?

por Diaconescu, Razvan, Little, Marie-Térèse, Leisenring, Wendy, Yunusov, Murad, Hogan, William J., Sorror, Mohamed L., Baron, Frédéric, Storb, Rainer
Publicado en Biol Blood Marrow Transplant (2005)

Pre-transplant expressions of microRNAs, comorbidities, and post-transplant mortality

por Sorror, Mohamed L., Gooley, Ted A., Maclean, Kirsteen H., Hubbard, Jesse, Marcondes, Mario A., Torok-Storb, Beverly J., Tewari, Muneesh
Publicado en Bone Marrow Transplant (2018)

Human Rhinovirus Infections in Hematopoietic Cell Transplant Recipients: Risk Score for Progression to Lower Respiratory Tract Infection

por Waghmare, Alpana, Xie, Hu, Kuypers, Jane, Sorror, Mohamed L., Jerome, Keith R., Englund, Janet A., Boeckh, Michael, Leisenring, Wendy M.
Publicado en Biol Blood Marrow Transplant (2019)

Comparable Outcomes after Nonmyeloablative Hematopoietic Cell Transplantation with Unrelated and Related Donors

por Mielcarek, Marco, Storer, Barry E., Sandmaier, Brenda M., Sorror, Mohamed L., Maloney, David G., Petersdorf, Effie, Martin, Paul J., Storb, Rainer
Publicado 2007

Allogeneic Hematopoietic Cell Transplantation Following Minimal Intensity Conditioning: Predicting Acute Graft-vs.-Host Disease and Graft-vs.-Tumor Effects

por Storb, Rainer, Gyurkocza, Boglarka, Storer, Barry E., Maloney, David G., Sorror, Mohamed L., Mielcarek, Marco, Martin, Paul J., Sandmaier, Brenda M.
Publicado 2013